Filer Snapshot

Malin Life Sciences Holdings Ltd SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001685138.

Entity Type

Company

Total Filings

17

Latest Filing

15 Jan 2025

Industry

n/a

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Schedule 13D/G

SCHEDULE 13G/A filed on 15 Jan 2025 for CIK 0001685138.

View Source Filing
Business address
2 Harbour Square, Crofton Road, Dun Laoghaire, Co, Dublin, Ireland, ----
Top holdings (Schedule 13G)
PSTX
State of incorporation
Ireland
Fiscal year end
31 December

Quick Takeaways

  • Malin Life Sciences Holdings Ltd is an SEC filer tracked under CIK 0001685138.
  • 17 filings are listed on this profile.
  • Common form coverage includes SCHEDULE 13G/A, 4, SC 13G/A and more.

What Changed

  • Latest filing: SCHEDULE 13G/A filed on 15 Jan 2025.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Schedule 13D/G

SCHEDULE 13G/A filed on 15 Jan 2025 for CIK 0001685138.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed SCHEDULE 13G/A can change the filing history, ownership context, or next research path for Malin Life Sciences Holdings Ltd.

Latest source-backed update
SCHEDULE 13G/A filed 15 Jan 2025
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: SCHEDULE 13G/A filed 15 Jan 2025.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Latest update

What changed recently for Malin Life Sciences Holdings Ltd

New filing available

Latest Schedule 13D/G period: 08 Jan 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

15 Jan 2025

Page type

Filer profile

Latest period

08 Jan 2025

Schedule 13D/G context is visible from filings filed on 15 Jan 2025.

Benchmark Context

Benchmark context for this company

Malin Life Sciences Holdings Ltd has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 08 Jan 2025. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Filer Overview

Malin Life Sciences Holdings Ltd has filed 17 SEC EDGAR filings since 20 Sep 2016. Common forms include SCHEDULE 13G/A, 4, SC 13G/A, SC 13G and more.

Latest Filings

Recent SEC filings for Malin Life Sciences Holdings Ltd with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 15 Jan 2025
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 10 Jan 2025 08 Jan 2025 001-39376
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 07 Sep 2022
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 10 Aug 2022 08 Aug 2022 001-39376
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 10 Feb 2022
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 07 Dec 2021 06 Dec 2021 001-39376
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 02 Dec 2021 30 Nov 2021 001-39376
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 29 Nov 2021 24 Nov 2021 001-39376
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 23 Nov 2021 19 Nov 2021 001-39376
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 18 Nov 2021 16 Nov 2021 001-39376
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 15 Oct 2021
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 03 Feb 2021
4 Open 4 document View SEC filing for 4 4 15 Jul 2020 14 Jul 2020 001-39376
3 Open 3 document View SEC filing for 3 3 09 Jul 2020 09 Jul 2020 001-39376
4 Open 4 document View SEC filing for 4 4 02 Jul 2019 28 Jun 2019 001-37880
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 28 Sep 2016 26 Sep 2016 001-37880
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 20 Sep 2016 20 Sep 2016 001-37880

About this filer

Malin Life Sciences Holdings Ltd files with the SEC under CIK 0001685138. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .